Clinical Trials Directory

Trials / Completed

CompletedNCT03774862

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
13 (actual)
Sponsor
V.K.V. American Hospital, Istanbul · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Medullary carcinoma (MC) is a rare tumor with solid growth pattern without glandular differentiation and constitute less than 1% of colorectal cancer. Lymph node positivity and distant organ metastasis were reported to be lower than other poorly differentiated adenocarcinomas. Therefore, the diagnosis of MC is pathologically important in terms of follow-up and treatment. MC is commonly localized in the right colon, has a large tumor size, and is mostly diagnosed in the T4 stage. As MC most likely have defects in DNA MMR, the correct pathological diagnosis is important for the postoperative treatment and the prognosis of the patients.

Detailed description

427 patients with colorectal cancer who were underwent surgery between January 2011 and December 2017, were evaluated retrospectively into 2 groups as MC (n:13) and non-MC (n:414) in terms of demographic characteristics, pathological data and oncological outcomes.

Conditions

Timeline

Start date
2011-01-01
Primary completion
2017-12-31
Completion
2018-08-01
First posted
2018-12-13
Last updated
2018-12-13

Source: ClinicalTrials.gov record NCT03774862. Inclusion in this directory is not an endorsement.